Founder, Chair, and CEO of Lysogene, Ms. Karen Pignet-Aiach is also the mother of a child with MPS IIIA.

Dr. Ralph Laufer is responsible for Lysogene’s scientific activities.

Dr. Marie Deneux is in charge of defining and executing the regulatory strategy for the development and registration…

Dr. Marie Trad, M.D., Chief Medical Officer is responsible for Lysogene’s medical and clinical development activities…